Increasing the precision of gene editing in vitro, ex vivo, and in vivo

被引:8
|
作者
Mueller, Katherine [1 ,2 ]
Carlson-Stevermer, Jared [1 ,2 ]
Saha, Krishanu [1 ,2 ]
机构
[1] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA
[2] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA
基金
美国国家科学基金会;
关键词
Genome editing; Gene therapy; Cell therapy; CRISPR-Cas9; Precision medicine; Regenerative Medicine;
D O I
10.1016/j.cobme.2018.08.006
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
New gene editing tools like CRISPR-Cas9 enable precision genome engineering within cell lines, primary cells, and model organisms, with some formulations now entering the clinic. "Precision" applies to various aspects of gene editing, and can be tailored for each application. Here we review recent advances in four types of precision in gene editing: 1) increased DNA cutting precision (e.g., on-target:off-target nuclease specificity), 2) increased on-target knock-in of sequence variants and transgenes (e.g., increased homology-directed repair), 3) increased transcriptional control of edited genes, and 4) increased specificity in delivery to a specific cell or tissue. Design of next-generation gene and cell therapies will likely exploit a combination of these advances.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [31] Correcting CFTR: New Gene Editing Strategies for Rescuing CFTR Function Ex Vivo
    Ryan, Amy L.
    CELL STEM CELL, 2020, 26 (04) : 476 - 478
  • [32] Silicon-Nanotube-Mediated Intracellular Delivery Enables Ex Vivo Gene Editing
    Chen, Yaping
    Aslanoglou, Stella
    Murayama, Takahide
    Gervinskas, Gediminas
    Fitzgerald, Laura I.
    Sriram, Sharath
    Tian, Jie
    Johnston, Angus P. R.
    Morikawa, Yasuhiro
    Suu, Koukou
    Elnathan, Roey
    Voelcker, Nicolas H.
    ADVANCED MATERIALS, 2020, 32 (24)
  • [33] Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes
    Zabulica, Mihaela
    Srinivasan, Raghuraman C.
    Akcakaya, Pinar
    Allegri, Gabriella
    Bestas, Burcu
    Firth, Mike
    Hammarstedt, Christina
    Jakobsson, Tomas
    Jakobsson, Towe
    Ellis, Ewa
    Jorns, Carl
    Makris, Georgios
    Scherer, Tanja
    Rimann, Nicole
    van Zuydam, Natalie R.
    Gramignoli, Roberto
    Forslow, Anna
    Engberg, Susanna
    Maresca, Marcello
    Rooyackers, Olav
    Thony, Beat
    Haberle, Johannes
    Rosen, Barry
    Strom, Stephen C.
    MOLECULAR THERAPY, 2021, 29 (05) : 1903 - 1917
  • [34] Gene editing of keratinocyte stem cells for a novel ex vivo epidermolytic ichthyosis therapy
    March, O.
    Aushev, M.
    Koller, U.
    Reichelt, J.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E17 - E17
  • [35] Ex vivo gene delivery for meniscus healing in an novel in vitro model
    Steinert, A.
    Palmer, G.
    Capito, R.
    Hofstaetter, J.
    Pilapil, C.
    Ghivizzani, S. C.
    Spector, M.
    Evans, C.
    CYTOTHERAPY, 2006, 8 : 28 - 29
  • [36] Editing outside the body : Ex vivo gene-modification for β-hemoglobinopathy cellular therapy
    Rosanwo, Tolulope O.
    Bauer, Daniel E.
    MOLECULAR THERAPY, 2021, 29 (11) : 3163 - 3178
  • [37] The future of ex vivo hematopoietic stem cell gene editing: what's next
    Cavazza, Alessia
    Santilli, Giorgia
    REGENERATIVE MEDICINE, 2025,
  • [38] Editing the Genome Ex Vivo Stem Cell Therapy
    Fan Y.
    Chan J.K.Y.
    Current Stem Cell Reports, 2018, 4 (4) : 338 - 345
  • [39] Photobinding of ketoprofen in vitro and ex vivo
    Moser, J
    Sarabia, Z
    Minter, H
    Lovell, WW
    van Henegouwen, GMJB
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2000, 58 (01) : 37 - 45
  • [40] In Vivo Delivery of Gene Editing Agents
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (05) : 987 - 987